Who owns ABEONA THERAPEUTICS INC?
- Ticker: ABEO
- CUSIP Number: 00289y206
Tip: Access positions for across all investors
Analyze quarterly positions in Abeona Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abeona Therapeutics stock
Who bought or sold ABEONA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Adage Capital Partners GP | 3.2M | $24M | 0% | Mar 2024 |
|
| Nantahala Capital Management | 2.8M | $21M | 2% | Mar 2024 |
|
| Millennium Management | 2.0M | $15M | 44% | Mar 2024 |
|
| Western Standard | 1.4M | $9.9M | 68% | Mar 2024 |
|
| Vanguard Group | 1.1M | $8.0M | 0% | Mar 2024 |
|
| Ikarian Capital | 956k | $6.9M | 59% | Mar 2024 |
|
| Laurion Capital Management | 647k | $4.7M | 100% | Mar 2024 |
|
| Citigroup | 484k | $3.5M | 7% | Mar 2024 |
|
| Boothbay Fund Management | 290k | $2.1M | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 266k | $1.9M | 42% | Mar 2024 |
|
| Geode Capital Management | 242k | $1.8M | 23% | Mar 2024 |
|
| BlackRock | 221k | $1.6M | 56% | Mar 2024 |
|
| Goldman Sachs Group | 172k | $1.2M | 100% | Mar 2024 |
|
| Marshall Wace | 129k | $935k | 169% | Mar 2024 |
|
| Northern Trust | 129k | $933k | 18% | Mar 2024 |
|
| Bank of New York Mellon | 119k | $863k | 794% | Mar 2024 |
|
| Susquehanna International | 80k | $576k | -9% | Mar 2024 |
|
| Man Group | 74k | $535k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 73k | $528k | 100% | Mar 2024 |
|
| Hrt Financial | 69k | $500k | 100% | Mar 2024 |
|
| Jane Street | 65k | $468k | 58% | Mar 2024 |
|
| Barclays | 56k | $409k | -67% | Mar 2024 |
|
| Citadel Advisors | 51k | $369k | -54% | Mar 2024 |
|
| Jump Financial | 40k | $199k | 100% | Dec 2023 |
|
| Morgan Stanley | 31k | $225k | 559% | Mar 2024 |
|
| LPL Financial | 31k | $221k | 25% | Mar 2024 |
|
| GSA Capital Partners | 25k | $178k | 100% | Mar 2024 |
|
| Bank of America Corporation | 23k | $167k | -55% | Mar 2024 |
|
| J. Goldman & Co | 23k | $165k | -95% | Mar 2024 |
|
| Jpmorgan Chase & Co | 22k | $158k | 154643% | Mar 2024 |
|
| Balyasny Asset Management | 19k | $138k | 100% | Mar 2024 |
|
| Engineers Gate Manager | 18k | $129k | 100% | Mar 2024 |
|
| Tower Research Capital | 16k | $117k | 56% | Mar 2024 |
|
| Creative Planning | 15k | $109k | 100% | Mar 2024 |
|
| Squarepoint Ops | 15k | $105k | 45% | Mar 2024 |
|
| Palumbo Wealth Management | 14k | $104k | 100% | Mar 2024 |
|
| Y-Intercept | 14k | $102k | 100% | Mar 2024 |
|
| CI Private Wealth | 14k | $101k | 0% | Mar 2024 |
|
| Acadian Asset Management | 13k | $91k | 100% | Mar 2024 |
|
| UBS Group | 11k | $76k | 100% | Mar 2024 |
|
| Simplex Trading | 2.2k | $15k | -55% | Mar 2024 |
|
| Group One Trading | 1.8k | $13k | -82% | Mar 2024 |
|
| Advisor Group Holdings | 1.1k | $8.0k | -58% | Mar 2024 |
|
| Royal Bank of Canada | 800.00 | $6.0k | -21% | Mar 2024 |
|
| Hartford Financial Management | 720.00 | $5.2k | 0% | Mar 2024 |
|
| Parallel Advisors | 400.00 | $2.9k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 244.00 | $1.8k | 3% | Mar 2024 |
|
| Rhumbline Advisers | 58.00 | $420.001200 | 0% | Mar 2024 |
|
| FMR | 40.00 | $290.000000 | 100% | Mar 2024 |
|
| Highlander Capital Management | 1.00 | $7.000000 | 0% | Mar 2024 |
|
Who sold out of Abeona Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AIGH Capital Management | Dec 2023 | 788k | $3.9M |
| Point72 Asset Management | Dec 2023 | 761k | $3.8M |
| Worth Venture Partners | Dec 2023 | 196k | $984k |
| Alyeska Investment Group | Dec 2023 | 70k | $351k |
| Two Sigma Investments | Dec 2023 | 57k | $285k |
| Cambridge Trust Company | Sep 2023 | 13.00 | $55.000400 |